Data as of Jan 30
| +2.02 / +0.49%|
The 21 analysts offering 12-month price forecasts for Regeneron Pharmaceuticals have a median target of 450.00, with a high estimate of 519.00 and a low estimate of 332.00. The median estimate represents a +8.00% increase from the last price of 416.66.
The current consensus among 22 polled investment analysts is to Buy stock in Regeneron Pharmaceuticals. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.